颈动脉内膜切除术患者沉默性冠状动脉缺血的诊断与管理
本研究前瞻性纳入90例无心脏病史或症状的择期颈动脉内膜切除术患者,术前进行冠状动脉CTA和FFRCT检查。结果显示57%患者存在病变特异性冠状动脉缺血,43%为严重缺血;术后对36例显著缺血患者进行冠状动脉血运重建,30天无MACE事件,1年生存率100%,无MACE生存率98%。
要点
- 颈动脉内膜切除术患者中沉默性冠状动脉缺血患病率高(57%)。
- FFRCT可识别高风险患者并指导血运重建决策。
- 选择性术后血运重建可能降低心脏事件风险,但需更长随访。
核心结论
- 颈动脉内膜切除术患者存在高比例的未怀疑(沉默)冠状动脉缺血,可能面临冠状动脉事件风险。
- 术前使用CTA和FFRCT诊断沉默性缺血可识别高风险患者并指导管理。
- 对显著缺血患者选择性术后冠状动脉血运重建可能降低心脏事件风险并改善生存,但需要更长随访和前瞻性对照试验。
研究设计与样本
- 前瞻性、开放标签、机构审查委员会批准的研究,纳入90例无心脏病史或症状的择期颈动脉内膜切除术患者。
- 患者术前接受冠状动脉CTA和FFRCT检查,结果可供医生用于患者管理。
主要发现
- 病变特异性冠状动脉缺血(FFRCT≤0.80远端于FFRCT≤0.75的局灶性狭窄)见于51例患者(57%),平均FFRCT为0.71±0.14。
- 严重冠状动脉缺血见于39例患者(43%),26例有多支血管缺血,5例有左主干病变。
- 所有患者按计划完成CEA,无术后死亡或心肌梗死;30天无MACE事件。
- 36例显著病变特异性缺血患者术后接受冠状动脉造影,30例(33%)进行血运重建(PCI或CABG)。
- 1年生存率100%,无MACE生存率98%。
关键数值与推荐
- 病变特异性冠状动脉缺血定义为FFRCT≤0.80远端于FFRCT≤0.75的局灶性冠状动脉狭窄。
- 严重缺血定义为FFRCT≤0.75。
- 主要终点为30天和1年主要不良心血管事件(MACE;定义为心血管死亡、心肌梗死或卒中)发生率。
临床怎么用
- 对接受CEA的无症状患者可考虑术前冠状动脉CTA和FFRCT筛查沉默性缺血。
- FFRCT提示显著缺血的患者可选择术后冠状动脉血运重建以降低心脏事件风险。
局限性
- 需要更长随访和前瞻性对照试验验证选择性术后血运重建的获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Coronary artery disease is the primary cause of death in patients with carotid artery disease and silent ischemia is a marker for adverse coronary events. A new noninvasive cardiac diagnostic test, coronary computed tomography-derived fractional flow reserve (FFRCT) can reliably identify ischemia-producing coronary stenosis in patients with coronary artery disease and help to select patients for coronary revascularization. The purpose of this study is to determine the prevalence of silent coronary ischemia in patients undergoing carotid endarterectomy (CEA) and to evaluate the usefulness of FFRCT in selecting patients for coronary revascularization to decrease cardiac events and improve survival. METHODS: Patients with no cardiac history or symptoms admitted for elective CEA were enrolled in a prospective, open-label, institutional review board-approved study and underwent preoperative coronary computed tomography angiography (CTA) and FFRCT with results available to physicians for patient management. Lesion-specific coronary ischemia was defined as FFRCT of 0.80 or less distal to a focal coronary stenosis with an FFRCT of 0.75 or less, indicating severe ischemia. Primary end point was incidence of major adverse cardiovascular events (MACE; defined as cardiovascular death, myocardial infarction, or stroke) at 30 days and 1 year. RESULTS: Coronary CTA and FFRCT was performed in 90 CEA patients (age 67 ± 8 years; male 66%). Lesion-specific coronary ischemia was found in 51 patients (57%) with a mean FFRCT of 0.71 ± 0.14. Severe coronary ischemia was present in 39 patients (43%), 26 patients had multivessel ischemia, and 5 had left main disease. CEA was performed as scheduled in all patients with no postoperative deaths or myocardial infarctions. There were no MACE events at 30 days. After recovery from surgery, 36 patients with significant lesion-specific ischemia underwent coronary angiography with coronary revascularization (percutaneous coronary intervention or coronary artery bypass grafting) in 30 patients (33%). Survival at 1 year was 100% and freedom from MACE was 98%. CONCLUSIONS: Patients undergoing CEA have a high prevalence of unsuspected (silent) coronary ischemia, which may place them at risk for coronary events. Preoperative diagnosis of silent ischemia using CTA and FFRCT can identify high-risk patients and help to guide patient management. Selective postoperative coronary revascularization of patients with significant ischemia may decrease the risk of cardiac events and improve survival, but longer follow-up is needed and prospective, controlled trials are indicated.
引用
- Krievins D, Zellans E, Latkovskis G, et al. Diagnosis and management of silent coronary ischemia in patients undergoing carotid endarterectomy. J Vasc Surg. 2020. PMID: 32623107. doi:10.1016/j.jvs.2020.06.045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。